Title:
Artificial, sequence-specific ribonucleases as potential therapeutics
Project management at the University of Würzburg:
Participating scientists:
Abstract:
Metabolically stable, sequence-specific oligonucleotedes carrying the covalently bound catalytical center of natural ribonucleases are being developed for the specific cleavage of pathogenic (bacterial, viral) RNAs and oncogenic mRNAs, respectively, as an alternative to gene therapy.
Key words:
Artificial Ribonucleases
Projekt period: from 10.1997 to 09.2000
Funding institution:
Sonstige Stiftung ,Granting date: 17.09.1997
Publications: